Magnetic nanoparticles for drug delivery
By Jon Dobson. 2006
1,263 citations recorded by the source corpus.
Subfields: Biomaterials, Biomedical Engineering
View Paper: https://www.semanticscholar.org/paper/06696992862e4e6c957bd4256749064726438747
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
In Biomedical Engineering
Citations in the corpus
- Progress in applications of magnetic nanoparticles in biomedicine (2009, background): “As discussed in our previous review of this subject [1], physical constraints placed upon magnetic targeting, such as the rapid diminishing of field strength with target depth in the body and the difficulties of bypassing intervening vasculature and tissue structures [2, 3 ], have hampered the clin”
- Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers (2012, positive): “Magnetic focusing uses external magnets to create a suitable magnetic field gradient over the targeted area and ensure significant accumulation of drug-loaded SPIONs.(57) The strength of the applied magnetic field can be altered to modulate release of the drug in the desired fashion, resulting in ma”
- Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. (2011, background): “[161,162] It is notable that most of the current clinically approved nanotechnology products relatively experience the passive targeting approach (i.”
- Tuning the Magnetic Properties of Nanoparticles (2013, background): “Saturation magnetization (Ms) Biosensing [5], Drug Delivery [7,8], Magnetic Resonance Imaging (MRI) [22] Coercivity (Hc) Biosensing [5], Hyperthermia [9] Blocking temperature (TB) Biosensing, Drug Delivery [7,8], Hyperthermia [9] Neel and Brownian relaxation time of nanoparticles (tN & tB) Biosensin”
- Magnetic nanoparticles for gene and drug delivery (2008, positive): “The theory and physical principles of magnetic nanoparticle-based drug and gene targeting have been reviewed elsewhere (Pankhurst et al 2003; Grief and Richardson 2005; Dobson 2006a, 2006b, 2006c).”
- Magnetic separations: From steel plants to biotechnology (2009, result): “As can be clearly seen in FeRx example, physical (magnetic properties to drug binding capacity) and physiological (target position to bodyweight) limitations for the in vivo studies resulted in unsuccessful medical therapies but also encouraged more in depth research (Dobson, 2006).”
- Magnetic nanoparticles in MR imaging and drug delivery. (2008, methodology): “To overcome this problem, MDT utilizes the attraction of MNP carriers to an external magnetic field to increase site-specific delivery of therapeutic agents [2,3].”
- Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. (2007, methodology): “Magnetic nanoparticles have been used for cell sorting [14–17], MRI [18–24], drug delivery [25–28] and magnetic hyperthermia therapy [29–34].”
- A Review on Nanofluids: Preparation, Stability Mechanisms, and Applications of Ethylene Glycol – Water Based Nanofluids Dispersed with Multi Walled Carbon Nanotubes (2024, background): “[43] M.”
- Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications (2015, background): “magnetic particles are heated selectively by application of a high-frequency magnetic field [305].”